Pulmonary precapillary arterioles and capillaries

Pulmonary precapillary arterioles and capillaries are the terminal components of the pulmonary arterial tree, serving as the primary site for gas exchange and the regulation of pulmonary vascular resistance (NIH, 2022). Precapillary arterioles, typically less than 100 micrometers in diameter, contain smooth muscle cells that modulate blood flow into the capillary beds where oxygen and carbon dioxide exchange occurs across the alveolar-capillary membrane (StatPearls, 2023). In pathological states such as pulmonary arterial hypertension (PAH), these vessels undergo significant structural remodeling, including medial hypertrophy and intimal fibrosis, which increases resistance and leads to right ventricular failure (American Heart Association, 2022). While these structures are anatomical regions rather than single molecular targets, they house critical proteins such as endothelin receptors, phosphodiesterase type 5 (PDE5), and soluble guanylate cyclase (sGC) that are the focus of therapeutic intervention (StatPearls, 2023). Drugs targeting these vessels aim to restore vascular tone and inhibit proliferative remodeling to improve hemodynamics and exercise capacity in patients (NIH, 2022). The capillaries specifically provide a massive surface area for diffusion, and their integrity is vital for preventing pulmonary edema (StatPearls, 2023). Dysfunction in these microvascular segments is also implicated in chronic obstructive pulmonary disease and acute respiratory distress syndrome (NIH, 2022). Consequently, the health and reactivity of the pulmonary microvasculature are central to the management of various cardiovascular and respiratory diseases.

Other names

Pulmonary resistance vesselsPulmonary microvasculatureDistal pulmonary arteriesPulmonary capillary bed

Pharmacological agents act on the cellular components of these vessels to induce vasodilation and inhibit remodeling. This is achieved through the inhibition of phosphodiesterase type 5 to increase cGMP, antagonism of endothelin receptors to block vasoconstriction, stimulation of soluble guanylate cyclase, or activation of prostacyclin receptors to promote cAMP-mediated relaxation (StatPearls, 2023; NIH, 2022).